Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic UCB Transfusion for Autism
NCT03786744Phase 2Completed
- Sponsor
- Samara Regional Medical Center Dinasty
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood mononuclear cells in Autism Spectrum Disorder (ASD), sponsored by Samara Regional Medical Center Dinasty. Started Oct 2018; status: completed.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03786744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03786744.